331
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Structure-based virtual screening, molecular dynamics simulation and in vitro evaluation to identify inhibitors against NAMPT

, , , , &
Pages 10332-10344 | Received 11 Feb 2021, Accepted 07 Jun 2021, Published online: 06 Jul 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Diksha A. Varma, Mrityunjay Singh, Sharad Wakode, N. E. Dinesh, Simran Vinaik, Shailendra Asthana & Manisha Tiwari. (2023) Structure-based pharmacophore mapping and virtual screening of natural products to identify polypharmacological inhibitor against c-MET/EGFR/VEGFR-2. Journal of Biomolecular Structure and Dynamics 41:7, pages 2956-2970.
Read now

Articles from other publishers (3)

Yulu Wang, Amit Sharma, Fangfang Ge, Peng Chen, Yu Yang, Hongjia Liu, Hongde Liu, Chunxia Zhao, Lovika Mittal, Shailendra Asthana & Ingo G. H. Schmidt-Wolf. (2023) Non-oncology drug (meticrane) shows anti-cancer ability in synergy with epigenetic inhibitors and appears to be involved passively in targeting cancer cells. Frontiers in Oncology 13.
Crossref
Venkatanarayana Chowdary Maddipati, Lovika Mittal, Jaskaran Kaur, Yogita Rawat, Chandra Prakash Koraboina, Sankar Bhattacharyya, Shailendra Asthana & Rambabu Gundla. (2023) Discovery of non-nucleoside oxindole derivatives as potent inhibitors against dengue RNA-dependent RNA polymerase. Bioorganic Chemistry 131, pages 106277.
Crossref
Hao Qian, Cheng Lin, Dengwei Zhao, Shikui Tu & Lei Xu. (2022) AlphaDrug: protein target specific de novo molecular generation. PNAS Nexus 1:4.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.